164 related articles for article (PubMed ID: 20233842)
1. Targeting drug-metabolizing enzymes for effective chemoprevention and chemotherapy.
Swanson HI; Njar VC; Yu Z; Castro DJ; Gonzalez FJ; Williams DE; Huang Y; Kong AN; Doloff JC; Ma J; Waxman DJ; Scott EE
Drug Metab Dispos; 2010 Apr; 38(4):539-44. PubMed ID: 20233842
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors and prodrugs targeting CYP1: a novel approach in cancer prevention and therapy.
Cui J; Li S
Curr Med Chem; 2014; 21(5):519-52. PubMed ID: 24083611
[TBL] [Abstract][Full Text] [Related]
3. Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.
D'Uva G; Baci D; Albini A; Noonan DM
Cancer Treat Rev; 2018 Feb; 63():1-18. PubMed ID: 29197745
[TBL] [Abstract][Full Text] [Related]
4. Polycyclic aromatic hydrocarbon-induced CYP1B1 activity is suppressed by perillyl alcohol in MCF-7 cells.
Chan NL; Wang H; Wang Y; Leung HY; Leung LK
Toxicol Appl Pharmacol; 2006 Jun; 213(2):98-104. PubMed ID: 16307765
[TBL] [Abstract][Full Text] [Related]
5. Challenges of cancer drug design: a drug metabolism perspective.
Sanchez RI; Mesia-Vela S; Kauffman FC
Curr Cancer Drug Targets; 2001 May; 1(1):1-32. PubMed ID: 12188889
[TBL] [Abstract][Full Text] [Related]
6. Discovery of cytochrome P450 1B1 inhibitors as new promising anti-cancer agents.
Chun YJ; Kim S
Med Res Rev; 2003 Nov; 23(6):657-68. PubMed ID: 12939788
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 1B1: a novel anticancer therapeutic target.
McFadyen MC; Murray GI
Future Oncol; 2005 Apr; 1(2):259-63. PubMed ID: 16555997
[TBL] [Abstract][Full Text] [Related]
8. P450-dependent enzymes as targets for prostate cancer therapy.
De Coster R; Wouters W; Bruynseels J
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):133-43. PubMed ID: 8603034
[TBL] [Abstract][Full Text] [Related]
9. Drug-metabolizing enzymes: mechanisms and functions.
Sheweita SA
Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of steroidal cytochrome p450 enzymes as targets for drug development.
Baston E; Leroux FR
Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):31-58. PubMed ID: 18221052
[TBL] [Abstract][Full Text] [Related]
11. Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1.
Courter LA; Musafia-Jeknic T; Fischer K; Bildfell R; Giovanini J; Pereira C; Baird WM
Toxicol Sci; 2007 Jan; 95(1):63-73. PubMed ID: 17060372
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
13. Phytotherapeutic approach: a new hope for polycyclic aromatic hydrocarbons induced cellular disorders, autophagic and apoptotic cell death.
Das DN; Panda PK; Naik PP; Mukhopadhyay S; Sinha N; Bhutia SK
Toxicol Mech Methods; 2017 Jan; 27(1):1-17. PubMed ID: 27919191
[TBL] [Abstract][Full Text] [Related]
14. Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.
Bruno RD; Njar VC
Bioorg Med Chem; 2007 Aug; 15(15):5047-60. PubMed ID: 17544277
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
[TBL] [Abstract][Full Text] [Related]
16. Competitive inhibition of carcinogen-activating CYP1A1 and CYP1B1 enzymes by a standardized complex mixture of PAH extracted from coal tar.
Mahadevan B; Marston CP; Luch A; Dashwood WM; Brooks E; Pereira C; Doehmer J; Baird WM
Int J Cancer; 2007 Mar; 120(6):1161-8. PubMed ID: 17187366
[TBL] [Abstract][Full Text] [Related]
17. The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature.
Bird IM; Abbott DH
J Steroid Biochem Mol Biol; 2016 Oct; 163():136-46. PubMed ID: 27154414
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytochrome P450 (CYP) enzymes in human nonpigmented ciliary epithelial cells: induction of CYP1B1 expression by TCDD.
Volotinen M; Mäenpää J; Kankuri E; Oksala O; Pelkonen O; Nakajima M; Yokoi T; Hakkola J
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3099-105. PubMed ID: 19324859
[TBL] [Abstract][Full Text] [Related]
19. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
[TBL] [Abstract][Full Text] [Related]
20. Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa.
Rinaldi AL; Morse MA; Fields HW; Rothas DA; Pei P; Rodrigo KA; Renner RJ; Mallery SR
Cancer Res; 2002 Oct; 62(19):5451-6. PubMed ID: 12359752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
